| Company/Division name | Enable Injections, Inc.? |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 450 |
| Year reshoring announced: | 2024 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Springdale |
| State(s) reshored to: | OH |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | enFuse®?platform of wearable technology |
| What domestic positive factors made reshoring more attractive? | Higher productivity, Lead time/Time to market |
